By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CMC Biologics 

22021 20th Avenue SE

Bothell  Washington  98021  U.S.A.
Phone: 425-485-1900 Fax: 425-486-0300


SEARCH JOBS

CMC Biologics is a global contract process development and manufacturer of biopharmaceuticals. We offer our clients a full suite of contract services from DNA to API and leverage our technical expertise to transform these services into solutions that meet our clients’ near- and long-term objectives. With cGMP compliant facilities in both the United States and Europe and a team of more than 500 dedicated employees, every project is performed with our absolute commitment to quality manufacturing and customer satisfaction.

While our efforts touch a defined part of the expansive drug development and commercialization continuum, we see ourselves as partners in our clients’ success bringing products to patients. CMC Biologics has become our clients’ manufacturing partner of choice because they trust us to make their needs and objectives our own.


Key Statistics


Email:
Ownership: Private

Web Site: CMC Biologics
Employees:
Symbol: 
 



Industry
Manufacturing






Company News
CMC Biologics Recognized As A Leader In Contract Development And Manufacturing By Customers And The Biopharmaceutical Industry 3/29/2016 9:08:33 AM
CMC Biologics And IDT Biologika Announce A Strategic Collaboration To Manufacture Antibody Drug Conjugates 2/17/2016 11:18:59 AM
CMC Biologics Announces Appointment Of New CEO 10/20/2015 10:08:03 AM
Governor Inslee's Director Of Life Science And Global Health Development, Maura Little, Presides Over CMC Biologics' Ribbon Cutting Ceremony Commemorating The Bioreactor 6 Pack Manufacturing Facility 10/7/2015 9:44:42 AM
CMC Biologics Enters Into Agreement With The PATH Malaria Vaccine Initiative For Accelerated Development And Manufacturing Of Monoclonal Antibodies 8/12/2015 9:06:59 AM
CMC Biologics And River Vision Development Corporation Announce Manufacturing Agreement For RV001, A Monoclonal Antibody To Treat Grave's Orbitopathy 7/29/2015 12:57:03 PM
CMC Biologics Expands GMP Manufacturing Capacity In The United States 6/30/2015 7:06:16 AM
CMC Biologics Expands European GMP Manufacturing Capacity 5/20/2015 6:41:24 AM
CMC Biologics Expands GMP Manufacturing Capacity In The United States And Europe 5/7/2015 7:41:02 AM
CMC Biologics In Commercial Supply Agreement With Emergent BioSolutions (EBS) For FDA-Approved IXINITY 5/5/2015 6:14:36 AM
1234
//-->